非原始核酸によるDNAポリメラーゼβの非競争的阻害
A Hasan Howlader1, Xuanhe Jiang1, Zehui Zhou1
1Johns Hopkins University, Department of Chemistry, 3400 N. Charles St., Baltimore, Maryland 21218, United States.
The Journal of organic chemistry
|September 7, 2025
まとめ
DNA修復の鍵となる酵素である DNAポリメラーゼβ (Polβ) の強力な非共性阻害剤を特定しました これらの新しい核酸類は,Pol βを標的とした新しいがん治療薬の開発に有望な出発点を提供します.
科学分野:
- 生物化学
- 分子生物学
- 薬剤化学
背景:
- 塩基切除修復 (BER) は,ゲノムの安定性にとって極めて重要です.
- DNAポリメラーゼβ (Pol β) は,BRCA1/2欠乏症による癌および合成致死性に関与するBERの重要な酵素である.
研究 の 目的:
- DNAポリメラーゼβ (Polβ) の非共性阻害剤を発見し,特徴づけること.
- 生物化学の研究のツールとして,そして新しいがん治療法の導き手として,これらの阻害剤の潜在能力を探求する.
主な方法:
- 修正されたピリミジンヌクレオチドのライブラリから阻害剤のスクリーニングと識別.
- 抑制剤の効能 (Ki) と作用メカニズム (非競争的抑制) を決定する生化学的測定.
- 光アニソトロピーを含む構造的および運動的分析により,抑制剤の結合を理解する.
主要な成果:
- Ki値 ≤70nMの有力な非共性Polβ阻害剤の特定
- 最も強力な阻害剤がDNA結合を阻害することなくライアス領域に結合する非競争的阻害を示す.
- メチルメタネスルフォナートで観察された限られた細胞毒性シネジズム,抑制剤の細胞吸収にもかかわらず.
結論:
- 高効能で独特の結合特性を持つ新しい非共性Polβ阻害剤が開発されました.
- これらの阻害剤は,生化学的研究のための貴重なツールであり,標的がん治療の開発のための潜在的な出発点として機能します.
- 細胞活動と治療効果を高めるにはさらなる最適化が必要である.
関連する概念動画
Translesion DNA Polymerases
10.1K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.1K
Restarting Stalled Replication Forks
5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Proofreading
6.6K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
Errors During Replication are Corrected by the DNA Polymerase...
6.6K
Long-patch Base Excision Repair
7.2K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K
Enzyme Inhibition
79.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.5K
Single-Strand DNA Binding Proteins
14.9K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
14.9K


